Table 1.
Clinicopathologic characteristics of 124 cases from TCGA dataset THYM
| Clinicopathologic characteristics | n (%) | |
|---|---|---|
| Overall survival | Non-sensored | 114 (92.7) |
| Censored | 9 (7.3) | |
| Recurrence-free survival | Non-sensored | 109 (92.4) |
| Censored | 9 (7.6) | |
| Gender | Female | 60 (48.4) |
| Male | 64 (51.6) | |
| WHO histological types | A–B3 type | 113 (91.1) |
| C type | 11 (8.9) | |
| History myasthenia gravis | No | 87 (71.9) |
| Yes | 34 (28.1) | |
| Masaoka stage | I–IIB | 99 (81.1) |
| III–IV | 23 (18.9) | |
| Tumor tissue site | Thymus | 97 (78.2) |
| Anterior mediastinum | 27 (21.8) | |
| History of neoadjuvant treatment | No | 122 (98.4) |
| Yes | 2 (1.6) | |
| Postoperative radiotherapy and chemotherapy | No | 114 (92.7) |
| Yes | 9 (7.3) | |
| Radiation therapy | No | 80 (65.0) |
| Yes | 43 (35.0) | |